Stock Market & Financial Investment News

News Breaks March 6, 2013 10:57 EDT OSIR Osiris Therapeutics upgraded to Overweight from Neutral at Piper Jaffray News For OSIR From The Last 14 Days Check below for free stories on OSIR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 7, 2013 14:22 EDT OSIR Osiris Therapeutics price target raised to $14 from $11.50 at Piper Jaffray Subscribe for More Information 08:04 EDT OSIR Osiris Therapeutics reports Q1 EPS (8c), consensus (9c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.